Nawaloka Hospitals PLC (COSE:NHL.N0000)
Sri Lanka · Delayed Price · Currency is LKR 0.00
0.00 (0.00%)
Price not available due to exchange restrictions
Nawaloka Hospitals Financials Overview
Financials in millions LKR. Fiscal year is April - March.
Millions LKR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 13,818 | 13,243 | 11,013 | 10,379 | 9,305 | 15,302 |
Revenue Growth | 22.04% | 20.25% | 6.10% | 11.54% | -39.19% | 29.38% |
Gross Profit Gross Profit Growth | 7,736 | 7,332 | 5,692 | 5,617 | 4,635 | 7,841 |
Operating Income Operating Income Growth | 1,824 | 1,717 | 1,113 | 1,025 | -73.46 | 1,914 |
Net Income Net Income Growth | 390.76 | 1,054 | 56.38 | -304.75 | -2,438 | -96.59 |
Earnings Per Share EPS Growth | 0.28 | 0.75 | 0.04 | -0.22 | -1.73 | -0.07 |
EPS Growth | -41.14% | 1770.21% | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Unallocated/Eliminations Unallocated/Eliminations Growth | - | -0.16 | -0.09 | -0.26 | -0.79 | 0.56 |
Pharmaceutical Pharmaceutical Growth | 3,850 | 3,516 | 2,954 | 2,704 | 2,700 | 2,491 |
Radiology Services Radiology Services Growth | 1,538 | 1,444 | 1,151 | 988.61 | 883.72 | 857.56 |
Hospital Services Hospital Services Growth | 5,730 | 5,594 | 4,805 | 4,655 | 3,739 | 5,197 |
Laboratories Laboratories Growth | 2,700 | 2,689 | 2,103 | 2,031 | 1,983 | 6,756 |
Total Total Growth | 13,818 | 13,243 | 11,013 | 10,379 | 9,305 | 15,302 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 465.56 | 485.98 | 619.15 | 470.99 | 290.02 | 802.87 |
Total Debt Total Debt Growth | 7,989 | 8,236 | 7,784 | 7,505 | 8,142 | 9,658 |
Net Cash (Debt) Net Cash Growth | -7,524 | -7,750 | -7,165 | -7,034 | -7,852 | -8,855 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -5.33 | -5.50 | -5.08 | -4.99 | -5.57 | -6.28 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 2,089 | 769.85 | 1,133 | 2,124 | 2,885 | 2,375 |
Capital Expenditures CapEx Growth | -598.85 | -2,200 | -340.65 | -76.83 | -133.06 | -1,116 |
Free Cash Flow Free Cash Flow Growth | 1,490 | -1,430 | 792.79 | 2,047 | 2,752 | 1,259 |
Free Cash Flow Growth | - | - | -61.28% | -25.61% | 118.61% | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 55.99% | 55.36% | 51.69% | 54.12% | 49.81% | 51.24% |
Operating Margin | 13.20% | 12.96% | 10.10% | 9.87% | -0.79% | 12.51% |
Pretax Margin | 7.41% | 11.86% | 3.06% | -2.38% | -20.53% | 2.98% |
Profit Margin | 2.83% | 7.96% | 0.51% | -2.94% | -26.21% | -0.63% |
FCF Margin | 10.78% | -10.80% | 7.20% | 19.73% | 29.58% | 8.23% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 14, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 45.88 | 14.17 | 132.50 | - | - | - |
P/FCF Ratio | 12.02 | - | 9.42 | 2.69 | 2.92 | 7.28 |
PS Ratio | 1.30 | 1.13 | 0.68 | 0.53 | 0.86 | 0.60 |